Notably, the RNF213 p.Arg4810Lys variant carriers were identified in 6 out of 124 (4.8%) Japanese patients with CADASIL, indicating a significantly higher prevalence than the 1.5% found in the general population. This evidence concerns the gene RNF213 and CADASIL.